TB Drug Resistance in the U.S.: November 2013

Details

• Journal Article:
  CDC fact sheet
• Corporate Authors:
  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
• Description:
  Tuberculosis (TB) is a serious respiratory disease caused by bacteria that are spread from person to person through the air. In most cases, TB is treatable and curable; however, TB can be deadly without proper treatment. TB bacteria can become resistant to the drugs used for treatment. When this occurs, treatment is often still possible, but it is complex, long, challenging, and expensive. Rates of drug-resistant TB remain relatively low in the United States, though nearly half a million cases are estimated to occur globally each year.1 These cases underscore the need for ongoing vigilance and action, especially given the ease with which TB can spread through international travel and migration. The Centers for Disease Control and Prevention works with state and local health departments and other health care providers to prevent the spread of TB, track drug-resistant cases, assist with diagnosis as needed, and help ensure that patients with drug-resistant TB receive effective treatment and care.
• Subjects:
  Tuberculosis, Multidrug-Resistant Tuberculosis/epidemiology
• Source:
  CDC fact sheet
• Series:
  CDC Fact Sheet
• Document Type:
  Text
• Genre:
  Patient Education Handout
• Place as Subject:
  United States
• Pages in Document:
  4 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:6298a134a63ab9be40b5e3d757f9f89ffc201ced8a869d1941e0584a71f4010967167e81ef8ebf0eb3e6f5583678a78cac138c4ea07e451af23eaa13a30c5e16
• Download URL:
  https://stacks.cdc.gov/view/cdc/21302/cdc_21302_DS1.pdf
• File Type:
  [PDF - 218.03 KB ]